Do you want to help us improve human health and understand life on Earth? Make your mark by shaping the future to enable or deliver life-changing science to solve some of humanity’s greatest challenges.
What do we mean by ‘Projectification’? Projectification refers to the increasing trend of organizing work and resources around specific projects rather than traditional functional structures. It refers to the redesign of culture, systems, structures, people practices, rewards, measures - in order that an organisation becomes more fit for purpose for the future. Come along to learn more, share your views and find out what it will all mean for you.
LONDON, UK; HELSINKI, FINLAND; and NAPLES, ITALY – October 6, 2026 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led a search assignment for Valo Therapeutics Group ("Valo Therapeutics") and is pleased to announce the placement of Carlos de Sousa, M.D., MBA, as Chief Executive Officer.
Cancer Research UK have signed an agreement with ORIC Pharmaceuticals, Inc. to advance ORIC-259, a potential first-in-class CIP2A-targeted therapy, into clinical development.
Showcasing Cambridge & London life science, biotech, deeptech & techbio ventures, offering investors early insight, and emerging innovation.
There is often a distinction drawn between ‘Creative Industries’ and ‘Science and Technology Industries’ when describing economic development, career options and individual identities.
Over recent months One Nucleus has consulted widely on the why, what, and who aspects of choosing the right events to attend to balance cost, approaches, and expectations to meet the business needs most cost-effectively.
by Tony Jones, CEO, One Nucleus
In this article:
An exciting opportunity has arisen for a Project Coordinator to join Quadram Institute Bioscience (QIB)on a part-time basis (0.8 FTE, by negotiation) basis, providing coordination support to the Food Safety Research Network (FSRN) and, depending on the hours agreed, the AMR in Agrifood Systems Transdisciplinary Network (AMAST).
*Guest Article by Laura Murray, Head of Business Development, Cellular and Molecular Therapies, NHS Blood and Transplant (NHSBT). If you would like to submit an article or blog post please email [email protected].
As a Director, BioPharma R&D Strategy Analystyou will be responsible for connecting R&D strategy with commercial forecasting to improve the quality and impact of cross-functional decision-making.
Working across R&D and Commercial in a multidisciplinary team environment, the Director will lead the development oflong-term therapy area projections and strategic analyses that identify areas of high unmet need and inform portfolio prioritization.